Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma 225Lymphoma, Large B-Cell, Diffuse 160Precursor Cell Lymphoblastic Leukemia-Lymphoma 143Lymphoma, Non-Hodgkin 139Hodgkin Disease 106Burkitt Lymphoma 99Lymphoma, Follicular 85Leukemia 82Lymphoma, Mantle-Cell 76Lymphoma, Large-Cell, Immunoblastic 68Leukemia, Lymphocytic, Chronic, B-Cell 56Lymphoma, B-Cell, Marginal Zone 43Leukemia, Myeloid, Acute 34Recurrence 31Lymphoma, B-Cell 31Lymphoma, Large-Cell, Anaplastic 30Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 29Dendritic Cell Sarcoma, Interdigitating 29Lymphoma, Extranodal NK-T-Cell 26Multiple Myeloma 24Waldenstrom Macroglobulinemia 22Myelodysplastic Syndromes 22Lymphoma, T-Cell, Peripheral 22Lymphoma, T-Cell, Cutaneous 20Blast Crisis 19Lymphoma, T-Cell 18Leukemia, Myeloid, Accelerated Phase 18Immunoblastic Lymphadenopathy 18Congenital Abnormalities 18Neoplasms, Plasma Cell 16

Interventions

Vincristine 2Rituximab 2Prednisone 2Doxorubicin 2Cyclophosphamide 2pevonedistat 1Filgrastim 1Etoposide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acromesomelic dysplasia, Maroteaux type × Etoposide × Lymphoid × Clear all
NCT01415765 2019-12-17

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
LymphoidSarcoma

Acromesomelic dysplasia, Maroteaux type, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡